Literature DB >> 22422037

Neointimal tissue characteristics following sirolimus-eluting stent implantation: OCT quantitative tissue property analysis.

Jingbo Hou1, Haibo Jia, Haixia Liu, Zhigang Han, Shuang Yang, Chenyang Xu, Joseph Schmitt, Shaosong Zhang, Bo Yu, Ik-Kyung Jang.   

Abstract

The neointimal tissue characteristics inside sirolimus-eluting stent (SES) were evaluated by optical coherence tomography (OCT) according to follow-up duration. One hundred and thirty-three Optical coherence tomography was performed in 96 patients with 143 SES which were retrospectively included and divided into 2 groups according to follow-up duration: Group 1, <24 months (98 stents in 71 patients); Group 2, >24 months (35 stents in 25 patients). The neointimal tissue coverage pattern and characteristics were studied using a new OCT analysis system which can quantitatively analyze tissue property by measuring attenuation, backscatter and signal intensity in the region of interest. Using these parameters, a multivariable logistic regression model was constructed to divide neointima into homogenous or heterogeneous type. We defined homogeneous nointima as neointimal tissue having uniform optical properties and does not showing focal variations in backscattering pattern and heterogeneous neointima as neointimal tissue with focally changing optical properties and showing various backscattering patterns. The average time between stent implantation and follow-up OCT imaging was 1.2 years in Group 1 and 3.2 years in Group 2. The number of neointima covered cross-sections, neointimal thickness, and neointimal area increased significantly with the length of follow-up duration after SES implantation (P < 0.01). The incidence of heterogeneous neointima was higher in Group 2 than in Group 1 (P < 0.01). Heterogeneous neointima was associated with higher incidence of microvessels (P = 0.0023) and lipid rich plaque (P = 0.0015) compared with homogeneous neointima. The neointimal tissue characteristics may change over time after SES implantation. The incidence of heterogeneous pattern was higher in the SES group with longer follow-up duration. Microvessels and lipid rich plaques were more frequently observed in neointima with heterogeneous pattern. Neointimal heterogeneity could be an important factor for the late stability of SES.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422037     DOI: 10.1007/s10554-012-0031-7

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  29 in total

1.  Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound.

Authors:  Ik-Kyung Jang; Brett E Bouma; Dong-Heon Kang; Seung-Jung Park; Seong-Wook Park; Ki-Bae Seung; Kyu-Bo Choi; Milen Shishkov; Kelly Schlendorf; Eugene Pomerantsev; Stuart L Houser; H Thomas Aretz; Guillermo J Tearney
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

Review 2.  Inflammation and restenosis in the stent era.

Authors:  Frederick G P Welt; Campbell Rogers
Journal:  Arterioscler Thromb Vasc Biol       Date:  2002-11-01       Impact factor: 8.311

3.  Relation of microchannel structure identified by optical coherence tomography to plaque vulnerability in patients with coronary artery disease.

Authors:  Hironori Kitabata; Atsushi Tanaka; Takashi Kubo; Shigeho Takarada; Manabu Kashiwagi; Hiroto Tsujioka; Hideyuki Ikejima; Akio Kuroi; Hideaki Kataiwa; Kohei Ishibashi; Kenichi Komukai; Takashi Tanimoto; Yasushi Ino; Kumiko Hirata; Nobuo Nakamura; Masato Mizukoshi; Toshio Imanishi; Takashi Akasaka
Journal:  Am J Cardiol       Date:  2010-06-15       Impact factor: 2.778

4.  Late angiographic stent thrombosis (LAST) events with drug-eluting stents.

Authors:  Andrew T L Ong; Eugène P McFadden; Evelyn Regar; Peter P T de Jaegere; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

5.  Remodeling of in-stent neointima, which became thinner and transparent over 3 years: serial angiographic and angioscopic follow-up.

Authors:  M Asakura; Y Ueda; S Nanto; A Hirayama; T Adachi; M Kitakaze; M Hori; K Kodama
Journal:  Circulation       Date:  1998-05-26       Impact factor: 29.690

6.  Early time course of neointima formation and vascular remodelling following percutaneous coronary intervention and vascular brachytherapy of in-stent restenotic lesions as assessed by intravascular ultrasound analysis.

Authors:  A Zimmermann; B Pöllinger; J Rieber; A König; I Erhard; F Krötz; H-Y Sohn; R Kantlehner; W Haimerl; E Dühmke; M Leibig; K Theisen; V Klauss; T M Schiele
Journal:  Z Kardiol       Date:  2005-04

7.  Apoptosis in human atherosclerosis and restenosis.

Authors:  J M Isner; M Kearney; S Bortman; J Passeri
Journal:  Circulation       Date:  1995-06-01       Impact factor: 29.690

8.  Leukocyte recruitment and expression of chemokines following different forms of vascular injury.

Authors:  Frederick G P Welt; Colin Tso; Elazer R Edelman; Michael A Kjelsberg; John F Paolini; Philip Seifert; Campbell Rogers
Journal:  Vasc Med       Date:  2003       Impact factor: 3.239

9.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

10.  Different patterns of neointimal coverage between acute coronary syndrome and stable angina after various types of drug-eluting stents implantation; 9-month follow-up optical coherence tomography study.

Authors:  Jung-Sun Kim; Chunyu Fan; Donghoon Choi; Ik-Kyung Jang; Jung Myung Lee; Tae Hoon Kim; Sang Min Park; Sung Il Paik; Young-Guk Ko; Myeong-Ki Hong; Yangsoo Jang; Namsik Chung
Journal:  Int J Cardiol       Date:  2009-08-25       Impact factor: 4.164

View more
  3 in total

Review 1.  Cardiovascular imaging 2012 in the International Journal of Cardiovascular Imaging.

Authors:  Hiram G Bezerra; Ricardo A Costa; Johan H C Reiber; Frank J Rybicki; Paul Schoenhagen; Arthur A Stillman; Johan De Sutter; Nico R L Van de Veire; Ernst E van der Wall
Journal:  Int J Cardiovasc Imaging       Date:  2013-04       Impact factor: 2.357

2.  A comparison of procedural success rate and long-term clinical outcomes between in-stent restenosis chronic total occlusion and de novo chronic total occlusion using multicenter registry data.

Authors:  Seung Hun Lee; Jae Young Cho; Je Sang Kim; Hyun Jong Lee; Jeong Hoon Yang; Jae Hyoung Park; Soon Jun Hong; Rak Kyeong Choi; Seung-Hyuk Choi; Hyeon-Cheol Gwon; Do-Sun Lim; Cheol Woong Yu
Journal:  Clin Res Cardiol       Date:  2019-09-24       Impact factor: 5.460

3.  Methotrexate Therapy Promotes Cell Coverage and Stability in in-Stent Neointima.

Authors:  Xianglan Liu; Ruoxi Zhang; Guosheng Fu; Yong Sun; Jian Wu; Maomao Zhang; Jinwei Tian; Xia Gu; Yang Zheng; Chengming Shi; Jingbo Hou; Bo Yu
Journal:  Cardiovasc Drugs Ther       Date:  2021-01-04       Impact factor: 3.727

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.